Inventurus Knowledge Solutions Ltd

Inventurus Knowl Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Inventurus Knowledge Solutions Ltd

₹ 1,880 -2.48%
21 Jan 1:05 p.m.
ikshealth.com BSE: 544309 NSE: IKS
About

Incorporated in 2006, Inventurus Knowledge Solutions Ltd provides healthcare solutions through its care enablement platform[1]

Key Points

Business Overview:[1]
IKSL is a technology-enabled healthcare solutions provider which offer a care enablement platform assisting physician enterprises in the US, Canada and Australia, with a focus on the US markets. It partners with an outpatient and inpatient health care organizations, enabling them to deliver superior clinical care through a **fee for value model **

Website BSE NSE
  • Market Cap ₹ 32,253 Cr.
  • Current Price ₹ 1,880
  • High / Low ₹ 2,190 / 1,820
  • Stock P/E 95.8
  • Book Value ₹
  • Dividend Yield 0.00 %
  • ROCE 46.7 %
  • ROE 45.9 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 46.7%

Cons

  • Promoter holding has decreased over last quarter: -6.01%
  • Debtor days have increased from 46.4 to 82.9 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: IT - Software Industry: Computers - Software - Medium / Small

Part of BSE IPO

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF
Upcoming result date: 5 February 2025

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
161 203 388 418 560 759 873
139 149 252 252 329 444 478
Operating Profit 22 54 136 166 231 316 394
OPM % 14% 27% 35% 40% 41% 42% 45%
0 0 31 16 1 -3 33
Interest 8 8 7 7 6 5 16
Depreciation 5 10 36 26 19 20 22
Profit before tax 8 36 123 148 208 288 390
Tax % 0% 0% 1% 6% 9% 12% 14%
8 36 122 139 189 253 337
EPS in Rs 10.51 44.55 148.09 168.19 11.04 14.83 19.72
Dividend Payout % 0% 0% 16% 14% 485% 0% 50%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 28%
TTM: 15%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 34%
TTM: 21%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 47%
Last Year: 46%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 8 8 8 8 17 17 17
Reserves -40 -2 221 368 501 622 811
74 79 0 62 53 43 227
58 66 141 62 133 154 101
Total Liabilities 100 151 370 500 704 836 1,156
16 32 36 72 63 49 116
CWIP 14 26 0 0 0 0 0
Investments 4 4 5 16 16 19 473
66 88 329 412 624 767 567
Total Assets 100 151 370 500 704 836 1,156

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
16 52 141 168 237 248 119
-21 -38 -80 -165 -81 -140 -149
5 -2 -36 -32 -54 -148 -186
Net Cash Flow 0 12 25 -30 102 -40 -216

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 130 101 35 23 25 32 83
Inventory Days
Days Payable
Cash Conversion Cycle 130 101 35 23 25 32 83
Working Capital Days -16 -22 -6 10 -48 -34 55
ROCE % 70% 47% 46% 52% 47%

Shareholding Pattern

Numbers in percentages

8 Recently
Dec 2024
63.72%
5.48%
4.45%
23.52%
2.85%
No. of Shareholders 67,583

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

No data available.

DRHP